UNSPSC 85893009: High dose rate (hdr) brachytherapy of pancreas using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pancreas using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DF139BZ

UNSPSC 85893009 High dose rate (HDR) brachytherapy of pancreas using palladium 103 (Pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single opportunity tagged under this code — Santa Clara County Health System's July 2026 RFQ for temporary health professional staffing services (due October 7, 2026) — is unrelated to the code's nominal scope of specialized cancer radiation therapy. The Health System's solicitation targets ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, orthopedic, and other ancillary health professional categories, establishing a multiple-award qualified vendor pool with no guaranteed work volume over a five-year term. This staffing-services procurement does not represent brachytherapy equipment, treatment planning, or clinical delivery.

State and local buyers do not appear to be actively procuring HDR brachytherapy services under this code at present. The mismatch between the code's medical-device and specialized-oncology focus and the actual staffing-services opportunity suggests either a tagging error in the source data or insufficient recent activity to support a meaningful market characterization. Business development professionals should verify whether opportunities in radiation oncology, cancer treatment centers, or health system capital equipment solicitations use higher-tier codes or different UNSPSC families before committing resources to this category.